Displaying drugs 5676 - 5700 of 6844 in total
Cortisone
A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)
Experimental
Divarasib
Investigational
Wheat germ oil
Experimental
inBreath airway transplant system
inBreath airway transplant system composes of a scaffold seeded with autologous bone marrow cells and incubated in the bioreactor for two days prior to implant.
Investigational
Pegylated synthetic human c-peptide
Investigational
Escherichia coli strain Nissle 1917
Experimental
CAM-GM201
Investigational
Phenyl trimethicone
Experimental
Autologous adipose derived mesenchymal stromal cells
Investigational
Etoposide toniribate
Investigational
Matched Iupac: … 1,3]dioxin-6-yl]oxy}-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-10 …
Enterococcus faecium
Experimental
Axatilimab
Axatilimab is under investigation in clinical trial NCT04301778 (Durvalumab in Combination With a CSF-1R Inhibitor (SNDX-6532) Following Chemo or Radio-embolization for Patients With Intrahepatic Cholangiocarcinoma).
Investigational
Acetylcysteine zinc
Experimental
Acetic Acid Salicyloyl-Amino-Ester
Experimental
Methyl salicylate 2-ethylbutyrate
Experimental
Potassium sodium hydrogen citrate
Experimental
ABBV-CLS-7262
Investigational
N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid
N(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.
Experimental
BBV152
BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or a novel TLR7/8 agonist adsorbed gel....
Investigational
CFT-8634
Investigational
Vepdegestrant
Vepdegestrant is under investigation in clinical trial NCT05909397 (A Study of ARV-471 (PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer).
Investigational
Displaying drugs 5676 - 5700 of 6844 in total